FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Svatava Tschöplová

Research Profile

Physiology

Genotype

Chemicals & Drugs

Procedures

Concepts & Ideas

Gene Frequency

Genes & Molecular Sequences

Disorders

Co-author Network

Publications

TOP 3
Anna Vasků; Monika Goldbergová; Lydie Izakovicová-Hollá; Lenka Sisková; Ladislav Groch; Michal Beránek; Svatava Tschöplová; Vladimír Znojil; Jirí Vácha
A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Michal Beránek; Katerina Kanková; Svatava Tschöplová; Petr Kolár; Jirí Vácha
Three novel polymorphisms in the promoter region of the TIMP-3 gene are not associated with proliferative diabetic retinopathy in type 2 diabetes mellitus.
Michal Beránek; Svatava Tschöplová; Katerina Kanková; Viera Kuhrová; Jirí Vácha
Genetic variation in the promoter region of the basic fibroblast growth factor gene.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Svatava Tschöplová (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Anna Vasků; Monika Goldbergová; Lydie Izakovicová-Hollá; Lenka Sisková; Ladislav Groch; Michal Beránek; Svatava Tschöplová; Vladimír Znojil; Jirí Vácha
A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Matrix biology : journal of the International Society for Matrix Biology 2004;22(7):585-91.
2003: Michal Beránek; Katerina Kanková; Svatava Tschöplová; Petr Kolár; Jirí Vácha
Three novel polymorphisms in the promoter region of the TIMP-3 gene are not associated with proliferative diabetic retinopathy in type 2 diabetes mellitus.
Current eye research 2003;27(2):91-3.
2003: Michal Beránek; Svatava Tschöplová; Katerina Kanková; Viera Kuhrová; Jirí Vácha
Genetic variation in the promoter region of the basic fibroblast growth factor gene.
Human immunology 2003;64(3):374-7.
2002: A Vasků; Miroslav Soucek; Svatava Tschöplová; Andrea Stejskalová
An association of BMI with A (-6) G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension.
Journal of human hypertension 2002;16(6):427-30.
2002: V Vasků; A Vasků; Svatava Tschöplová; Lydie Izakovicová-Hollá; V Semrádová; Jirí Vácha
Genotype association of C(-735)T polymorphism in matrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis.
Dermatology (Basel, Switzerland) 2002;204(4):262-5.
2000: V Vasků; A Vasků; Lydie Izakovicová-Hollá; Svatava Tschöplová; Katerina Kanková; N Benáková; V Semrádová
Polymorphisms in inflammation genes (angiotensinogen, TAP1 and TNF-beta) in psoriasis.
Archives of dermatological research 2000;292(11):531-4.
2000: A Vasků; Vladimír Znojil; Viera Kuhrová; Miroslav Soucek; Svatava Tschöplová; Jirí Vácha
[Interaction of mutations M235T of the gene for angiotensinogen and Taq I 8,000 in the gene for endothelin-1 at the onset of essential hypertension].
Casopís lékar̆ů c̆eských 2000;139(15):464-7.
1999: Lydie Izakovicová Hollá; V Kunrová; Svatava Tschöplová; Marcel Schüller; Marcel Stelcl; A Vasků
Polymorphism of the beta chain of the high affinity immunoglobulin E receptor (FcepsilonRI-beta) in South African black and white asthmatic and nonasthmatic individuals.
American journal of respiratory and critical care medicine 1999;160(2):756-7.
1998: A Vasků; Miroslav Soucek; Vladimír Znojil; I Rihácek; Svatava Tschöplová; L Strelcová; K Cídl; M Blazková; Dobroslav Hájek; Lydie Izakovicová Hollá; Jirí Vácha
Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension.
Kidney international 1998;53(6):1479-82.